Ellagic acid and natural sources of ellagitannins as possible chemopreventive agents against intestinal tumorigenesis in the min mouse

Nutrition and Cancer

Volumn 54, Issue 1, 2006, Pages 79-83

  Päivärinta, Essi ^a   Pajari, Anne Maria ^a   Törrönen, Riitta ^b   Mutanen, Marja ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ELLAGIC ACID; ELLAGITANNIN;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; BERRY; CONFERENCE PAPER; CONTROLLED STUDY; DUODENUM; FEMALE; INTESTINE TUMOR; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; RUBUS CHAMAEMORUS; SMALL INTESTINE; TUMOR VOLUME;

ADENOMA; ANIMALS; ANTICARCINOGENIC AGENTS; ELLAGIC ACID; FEMALE; FRUIT; GENES, APC; HYDROLYZABLE TANNINS; INTESTINAL NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MUTATION; ROSACEAE; SEEDS;

RUBUS CHAMAEMORUS;

EID: 33746519946     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5401_9     Document Type: Conference Paper

References (39)

1. Khanduja KL, Gandhi RK, Pathania V, and Syal N: Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol 37, 313-318, 1999.
2. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, et al.: Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51, 4528-4534, 1991.
3. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, et al.: Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multi-organ carcinogenesis model. Cancer Lett 94, 113-121, 1995.
4. Hirose M, Akagi K, Hasegawa R, Yaono M, Satoh T, et al.: Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhlP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis 16, 217-221, 1995.
5. Siglin JC, Barch DH, and Stoner GD: Effects of dietary phenethyl isothiocyanate, ellagic acid, sulindac and calcium on the induction and progression of N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Carcinogenesis 16, 1101-1106, 1995.
6. Mandal S and Stoner GD: Inhibition of N-nitroso-benzylmethylamine-induced esophageal tumorigenesis in rats by ellagic acid. Carcinogenesis 11, 55-61, 1990.
7. de Boer JG, Yang H, Holcroft J, and Skov K: Chemoprotection against N-nitrosomethylbenzylamine-induced mutation in the rat esophagus. Nutr Cancer 50, 168-173, 2004.
8. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, et al.: The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis 17, 821-828, 1996.
9. 1-induced preneoplasia. Carcinogenesis 21, 1827-1834, 2000.
10. van der Logt KM, Roelofs HM, Nagengast FM, and Peters WH: Induction of rat hepatic and intestinal UDP-glucuronosyltransferases by naturally occurring dietary anticarcinogens. Carcinogenesis 24, 1651-1656, 2003.
11. Narayanan BA, Geoffroy O, Willingham MC, Re GG, and Nixon DW: p53/p2l (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136, 215-221, 1999.
12. Narayanan BA and Re GG: IGF-II down regulation associated cell cycle arrest in colon cancer cells exposed to phenolic antioxidant ellagic acid. Anticancer Res 21, 359-364, 2001.
13. Labrecque L, Lamy S, Chapus A, Mihoubi S, Durocher Y, et al.: Combined inhibition of PDGK and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 26, 821-826, 2005.
14. Losso JN, Bansode RR, Trappey A II, Bawadi HA, and Truax R: In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15, 672-678, 2004.
15. Han C, Ding H, Casto B, Stoner GD, and D'Ambrosio SM: Inhibition of the growth of premalignant and malignant human oral cell lines by extracts and components of black raspberries. Nutr Cancer 51, 207-217, 2005.
16. Teel RW and Martin RM: Disposition of the plant phenol ellagic acid in the mouse following oral administration by gavage. Xenobiotica 18, 397-405, 1988.
17. Smart RC, Huang M-T, Chang RL, Sayer JM, Jerina DM, et al.: Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3′-di-O-methylellagic acid in mice. Carcinogenesis 7, 1663-1667, 1986.
18. Doyle B and Griffiths LA: The metabolism of ellagic acid in the rat. Xenobiotica 10, 247-256, 1980.
19. Cerdá B, Llorach R, Cerón JJ, Espín JC, and Tomás-Barberán FA: Evaluation of the bioavailability and metabolism in the rat of punicalagin, an antioxidant polyphenol from pomegranate juice. Eur J Nutr 42, 18-28, 2003.
20. Cerdá B, Espin JC, Parra S, Martínez P, and Tomás-Barberán FA: The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43, 205-220, 2004.
21. Seeram NP, Lee R, and Heber D: Bioavailability of ellagic acid in human plasma after consumption of ellagitannins from pomegranate (Punica granatum L.) juice. Clin Chim Acta 348, 63-68, 2004.
22. Cerdá B, Tomás-Barberán KA, and Espín JC: Metabolism of antioxidant and chemopreventive ellagitannins from strawberries, raspberries, walnuts, and oak-aged wine in humans: identification of biomarkers and individual variability. J Agric Food Chem 53, 227-235, 2005.
23. Pereira MA and Khoury MD: Prevention by chemopreventive agents of azoxymethane-induced foci of aberrant crypts in rat colon. Cancer Lett 61, 27-33, 1991.
24. Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell 87, 159-170, 1996.
25. Häkkinen SH, Kärenlampi SO, Mykkänen HM, Heinonen IM, and Törrönen AR: Ellagic acid content in berries: influence of domestic processing and storage. Eur Food Res Technol 212, 75-80, 2000.
26. Määttä-Riihinen KR, Kamal-Eldin A, and Törrönen AR: Identification and quantification of phenolic compounds in berries of Fragaria and Rubus species (family Rosaceae). J Agric Food Chem 52, 6178-6187, 2004.
27. Päivärinta E, Pajari A-M, Törrönen R, and Mutanen M: Finnish wild berries decrease the number and size of intestinal adenomas in Min mice (abstract). Proc AACR 45, March 2004, abstract nr 3896.
28. Reeves PG, Nielsen FH, and Fahey GC Jr: AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition Ad Hoc Committee on the reformulation of the A1N-76A rodent diet. J Nutr 123, 1939-1951, 1993.
29. Dietrich WF, Lander ES, Smith JS, Moser AR, Could KA, et al.: Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 75, 631-639, 1993.
30. Pajari AM, Rajakangas J, Päivärinta E, Kosma VM, Rafter J, et al.: Promotion of intestinal tumor formation by inulin is associated with an accumulation of cytosolic β-catenin in Min mice. Int J Cancer 106, 653-660, 2003.
31. Min/+ mouse. Physiol Genomics 15, 228-235, 2003.
32. Whitley AC, Stoner GD, Darby MV, and Walle T: Intestinal epithelial cell accumulation of the cancer preventive polyphenol ellagic acid-extensive binding to protein and DNA. Biochem Pharmacol 66, 907-915, 2003.
33. Wätjen W, Michels G, Steffan B, Niering P, Chovolou Y, et al.: Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J Nutr. 135, 525-531, 2005.
34. Johansson A, Laakso P, and Kallio H: Characterization of seed oils of wild, edible Finnish berries. Z Lebensm Unters Forsch A 204, 300-307, 1997.
35. Mertens-Talcott SU, Talcott ST, and Percival SS: Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133, 2669-2674, 2003.
36. Mertens-Talcott SU and Percival SS: Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218, 141-151, 2005.
37. 21waf1/cip1, p53 and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135, 609-614, 2005.
38. Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, et al.: In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16, 360-367, 2005.
39. Häkkinen S, Heinonen M, Kärenlampi S, Mykkänen H, Ruuskanen J, et al.: Screening of selected flavonoids and phenolic acids in 19 berries. Food Res Int 32, 345-353, 1999.